| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.04. | Codexis, Inc.: Codexis to Report First Quarter 2024 Financial Results on May 2 | 2 | GlobeNewswire (USA) | ||
| 11.04. | Codexis, Inc.: Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board | 3 | GlobeNewswire (USA) | ||
| 06.03. | CODEXIS, INC. - 8-K, Current Report | 3 | SEC Filings | ||
| 01.03. | Benchmark raises Codexis to buy; cites Q4 earnings, guidance | 5 | Seeking Alpha | ||
| 01.03. | Earnings call: Codexis sees revenue growth, advances in RNA platform | 4 | Investing.com | ||
| 29.02. | Codexis Inc reports results for the quarter ended in December - Earnings Summary | 6 | Reuters | ||
| 28.02. | Recap: Codexis Q4 Earnings | 4 | Benzinga.com | ||
| 28.02. | Codexis, Inc.: Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results | 903 | GlobeNewswire (Europe) | Anticipate 2024 Product Revenue Growth of at Least 10% vs. 2023 Excluding Enzyme Sales Related to PAXLOVID Recently Announced Debt Financing Reinforces Strong Financial Position with Projected Runway... ► Artikel lesen | |
| 27.02. | Codexis Q4 2023 Earnings Preview | 6 | Seeking Alpha | ||
| 26.02. | Codexis, Inc.: Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche | 237 | GlobeNewswire (Europe) | REDWOOD CITY, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has entered into an agreement with Roche for an exclusive... ► Artikel lesen | |
| 26.02. | Codexis, Inc.: Codexis to Participate in TD Cowen 44th Annual Health Care Conference | 2 | GlobeNewswire (USA) | ||
| 20.02. | Codexis, Inc.: Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board | 1 | GlobeNewswire (USA) | ||
| 16.02. | CODEXIS, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 14.02. | Codexis, Inc.: Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28 | 4 | GlobeNewswire (USA) | ||
| 13.02. | Codexis secures $40 million loan to advance RNAi platform | 2 | Investing.com | ||
| 13.02. | Codexis, Inc.: Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key Milestones | 3 | GlobeNewswire (USA) | ||
| 09.02. | CODEXIS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.02. | Codexis, Inc.: seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting | 178 | GlobeNewswire (Europe) | BEVERLY, Mass. and REDWOOD CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- seqWell, a global provider of genomic library workflow solutions, and Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering... ► Artikel lesen | |
| 09.01. | CODEXIS, INC. - 8-K, Current Report | 3 | SEC Filings | ||
| 27.12.23 | Codexis Clinches Deal With Nestlé Health Science, Eyes Up To $45M Milestone In EPI Treatment Breakthrough | 11 | Benzinga.com |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| AMAZON | 743 |
| SUPER MICRO COMPUTER | 722 |
| EVOTEC | 529 |
| NVIDIA | 447 |
| PFIZER | 443 |
| TESLA | 408 |
| CANOPY GROWTH | 360 |
| AMD | 358 |
| PAYPAL | 325 |
| BYD | 306 |
| DEUTSCHE BANK | 295 |
| STARBUCKS | 292 |
| NEL | 256 |
| BARRICK GOLD | 246 |
| BAYER | 243 |
| TUI | 235 |
| AURORA CANNABIS | 196 |
| MERCEDES-BENZ | 195 |
| PLUG POWER | 188 |
| TILRAY BRANDS | 177 |
| APPLE | 166 |
| CVS HEALTH | 153 |
| VOLKSWAGEN | 149 |
| COMMERZBANK | 142 |
| KRAFT HEINZ | 141 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
